Cyagen US Inc.
- UEI
- Q9J8WLRSYG63
- CAGE
- 884Y3
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- cyagen.com
- Founded
- 2005
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nichd - gene targeting services | National Institute of Child Health and Human Development | $48,455 | |
| Nichd - turboknockout mouse gene targeting | National Institute of Child Health and Human Development | $97,577 | |
| Knockin of GFP into the MYO10 locus in order to study the myosin function in different tissues | National Heart Lung and Blood Institute | $0 | |
| This firm fixed price purchase order is awarded for a "mouse tyrobp conditional knockin project (C57BL/6N)" to cyagen… | National Institute of Child Health and Human Development | $24,410 | |
| Long evans RAT nuclease knockout nuclease | National Institute on Deafness and Other Communincation Disorders | $21,963 |
About Cyagen US Inc.
Cyagen US Inc. is an emerging biotechnology company that specializes in generating knockout/transgenic mice, rats and cell line models, as well as virus packaging, vector cloning, stem cells and cell culture reagents. Through federal contract awards, Cyagen provides gene targeting services, turboknockout mouse gene targeting, and other scientific services to support biomedical research projects funded by agencies like the National Institutes of Health.
Past federal contract awards to Cyagen US Inc. reflect services such as gene targeting in mice, conditional mouse knockins, and nuclease knockouts in rat models. Specific projects have involved tagging the myosin protein with GFP to study tissue function, and conditional knockin of the TYROBP gene in a C57BL/6N mouse model. Contracting agencies have included the National Institute of Child Health and Human Development, National Heart Lung and Blood Institute, and National Institute on Deafness and Other Communication Disorders. Awards have been made via purchase orders, with no set aside designations. Potential value of individual awards has ranged from $21,963 to $97,577.
Quick answers
What is Cyagen US Inc.'s UEI?
Cyagen US Inc.'s Unique Entity ID (UEI) in SAM.gov is Q9J8WLRSYG63.
What is Cyagen US Inc.'s CAGE code?
Cyagen US Inc.'s CAGE code is 884Y3.
What is Cyagen US Inc.'s primary NAICS code?
Cyagen US Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Cyagen US Inc. registered in SAM.gov?
Cyagen US Inc.'s SAM.gov registration expired on February 1, 2024.
What is Cyagen US Inc.'s most recent federal award?
Cyagen US Inc.'s most recent federal contract award is Nichd - gene targeting services (75N94021P00691), from National Institute of Child Health and Human Development, on August 13, 2021.
On GovTribe
See Cyagen US Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors